Introduction When a patient has a serious or life-threatening condition that is not addressed by current approved treatments, options may exist to use an investigational medical device (i.e., one that has not been approved or cleared by FDA) to treat the patient. Normally, such investigational devices with significant risks may only be used on human…
Summary Information for: JUVÉDERM VOLBELLA® XC
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
MDUFA Quarterly Performance Report
%PDF-1.7% 53062 0 objendobj 53083 0 obj/Filter/FlateDecode/ID[]/Index[53062 62]/Info 53061 0 R/Length 106/Prev 2761759/Root 53063 0 R/Size 53124/Type/XRef/W[1 3 1]stream hbbd“`b`”oH~
Mycobacterium chimaera Infections Associated with Sorin Group Deutschland GmbH Stockert 3T Heater-Cooler System: FDA Safety Communication
June 1, 2016 Audiences Health care providers who use 3T Heater-Cooler System Primary care providers who are responsible for the ongoing care of patients who have undergone cardiothoracic surgery Patients who have undergone cardiothoracic surgery Hospital staff who are responsible for operating and maintaining 3T Heater-Cooler System Medical Specialties Cardiothoracic Surgeons, Cardiovascular Surgeons, Orthopedic Surgeons,…
FDA Categorization of Investigational Device Exemption (IDE) Devices to Assist the Centers for Medicare and Medicaid Services (CMS) with Coverage Decisions
%PDF-1.6% 470 0 objendobj 484 0 obj/Filter/FlateDecode/ID[]/Index[470 32]/Info 469 0 R/Length 77/Prev 256487/Root 471 0 R/Size 502/Type/XRef/W[1 2 1]stream hbbd“b`KS+`{$X9A{ ĺRf re q)1d #|
FDA Voice Blog: Celebrating a Year of the Expedited Access Pathway Program for Medical Devices
By: Erin Cutts, B.S., Owen Faris, Ph.D., and Jeffrey Shuren, M.D., J.D The U.S. Food and Drug Administration (FDA) is committed to supporting patient access to high-quality, safe, and effective medical devices of public health importance — as quickly as possible. Erin Cutts, B.S., Policy Lead, Q-Submission Program (acting), Office of Device Evaluation in FDA’s…
Meeting Materials posted for June 2-3, 2016 Circulatory System Devices Panel of the Medical Devices Advisory Committee
<!– –> <!– Page Last Updated: 05/31/2016 –> Page Last Updated: 05/31/2016 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Meeting Notice: August 10, 2016 Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-0001] Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Clinical Chemistry…
Meeting Notice: July 21-22, 2016 Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-0001] Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Clinical Chemistry…
2014 Ebola Virus Emergency Use Authorizations: Idylla™ Ebola Virus Triage Test (Biocartis NV)
OraQuick® Ebola Rapid Antigen Test (OraSure Technologies, Inc.) – For Use with whole Blood – July 31, 2015 On July 31, 2015, the FDA issued an Emergency Use Authorization (EUA) to authorize the emergency use of the OraQuick® Ebola Rapid Antigen Test for the presumptive detection of Ebola Zaire virus (detected in the West Africa…